Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPACE COPD exacerbation study
2005-001090-10Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Symbicort forte Turbuhaler acute treatment arm with Prednisolone + Oxis Turbuhaler acute treatment arm (2 arms). Primary endpoint: Forced Expiratory Volume in one second (FEV1). Started May 2005; status: completed.
02
Drugs
budesonide + formoterolprednisoloneformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-001090-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001090-10.